Callan Family Office LLC Acquires New Holdings in Envista Holdings Corporation $NVST

Callan Family Office LLC bought a new position in shares of Envista Holdings Corporation (NYSE:NVST) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 21,894 shares of the company’s stock, valued at approximately $577,000.

Several other hedge funds have also recently bought and sold shares of the stock. GSA Capital Partners LLP bought a new position in Envista during the 2nd quarter worth about $2,039,000. Dimensional Fund Advisors LP lifted its holdings in shares of Envista by 1.6% in the first quarter. Dimensional Fund Advisors LP now owns 9,780,948 shares of the company’s stock valued at $248,130,000 after purchasing an additional 152,488 shares in the last quarter. Pzena Investment Management LLC acquired a new position in shares of Envista during the second quarter worth about $30,494,000. SummitTX Capital L.P. acquired a new position in shares of Envista during the first quarter worth about $4,268,000. Finally, Principal Financial Group Inc. grew its holdings in shares of Envista by 36.8% during the first quarter. Principal Financial Group Inc. now owns 483,983 shares of the company’s stock worth $12,279,000 after buying an additional 130,237 shares in the last quarter.

Analysts Set New Price Targets

Several research firms have commented on NVST. Barclays cut their target price on Envista from $34.00 to $32.00 and set an “overweight” rating on the stock in a research note on Thursday, June 11th. Mizuho set a $29.00 price objective on shares of Envista in a report on Thursday, August 6th. BMO Capital Markets started coverage on shares of Envista in a report on Wednesday, July 8th. They set a “market perform” rating and a $27.00 target price for the company. Robert W. Baird set a $34.00 price target on shares of Envista in a research note on Thursday, August 6th. Finally, Piper Sandler reissued a “neutral” rating and set a $28.00 price target (up from $26.00) on shares of Envista in a research report on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $29.31.

Envista Price Performance

NYSE:NVST opened at $27.52 on Wednesday. The stock has a market capitalization of $4.42 billion, a PE ratio of 47.44, a P/E/G ratio of 1.30 and a beta of 0.86. Envista Holdings Corporation has a 1-year low of $18.77 and a 1-year high of $30.42. The firm has a fifty day simple moving average of $27.00 and a 200 day simple moving average of $26.36. The company has a current ratio of 2.43, a quick ratio of 2.07 and a debt-to-equity ratio of 0.47.

Envista (NYSE:NVST) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.07. Envista had a net margin of 3.33% and a return on equity of 7.88%. The firm had revenue of $730.50 million for the quarter, compared to analyst estimates of $716.11 million. During the same period in the prior year, the firm posted $0.26 earnings per share. The company’s quarterly revenue was up 7.1% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. On average, research analysts expect that Envista Holdings Corporation will post 1.53 EPS for the current fiscal year.

Insider Activity

In other news, SVP Mischa Reis sold 8,000 shares of the company’s stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $27.50, for a total value of $220,000.00. Following the sale, the senior vice president directly owned 27,321 shares of the company’s stock, valued at approximately $751,327.50. This represents a 22.65% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.99% of the company’s stock.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.